Treatment of Acute Bronchitis in Adults With a Pelargonium Sidoides Preparation (EPs® 7630): A Randomized, Double-Blind, Placebo-Controlled Trial

Explore: The Journal of Science and Healing

Volumn 1, Issue 6, 2005, Pages 437-445

  Chuchalin, A G ^a   Berman, B ^b   Lehmacher, W ^c  

^a Research Institute of Pulmonology   (Russian Federation)

^b UNIVERSITY OF MARYLAND   (United States)

^c UNIVERSITY HOSPITAL OF COLOGNE   (Germany)

Author keywords

Acute bronchitis; clinical trial; double blind; EPs 7630; herbal medicine; Pelargonium sidoides preparation; placebo controlled; randomized controlled trial

Indexed keywords

ACETYLCYSTEINE; ANTIBIOTIC AGENT; ANTITUSSIVE AGENT; EPS 7630; PARACETAMOL; PELARGONIUM SIDOIDES EXTRACT; PLACEBO; PLANT MEDICINAL PRODUCT; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BRONCHITIS; CALCULATION; CLINICAL TRIAL; CONFIDENCE INTERVAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CONVALESCENCE; DISEASE DURATION; DISEASE SEVERITY; DOUBLE BLIND PROCEDURE; DRUG DOSE REGIMEN; DRUG EFFICACY; DRUG INDICATION; DRUG SAFETY; EXPERIMENTAL DESIGN; FEMALE; FEVER; HUMAN; INFORMED CONSENT; MAJOR CLINICAL STUDY; MALE; OUTPATIENT DEPARTMENT; PELARGONIUM; PELARGONIUM SIDOIDES; PRIORITY JOURNAL; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; UNSPECIFIED SIDE EFFECT;

ACUTE DISEASE; ADULT; ANTI-INFECTIVE AGENTS; BRONCHITIS; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; FEMALE; HUMANS; MALE; MIDDLE AGED; PELARGONIUM; PHYTOTHERAPY; PLANT EXTRACTS; PROSPECTIVE STUDIES; QUALITY OF LIFE; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

EID: 33645814432     PISSN: 15508307     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.explore.2005.08.009     Document Type: Article

References (38)

1. Badura B., Lizsch M., and Vetter C. Fehlzeiten-Report (2000), Springer, Berlin-Heidelberg New York
2. Gonzales R., and Sande M.A. Uncomplicated acute bronchitis. Ann Intern Med 133 (2000) 981-991
3. Altiner A., and Abholz H.H. Akute Bronchitis und Antibiotika. Hintergründe für eine rationale Therapie. Z Allg Med 77 (2001) 358-362
4. Fahey T., and Howie J. Re-evaluation of a randomized controlled trial of antibiotics for minor respiratory illness in general practice. Fam Pract 18 (2001) 246-248
5. Murray S., Del Mar C., and O'Rourke P. Predictors of an antibiotic prescription by GPs for respiratory tract infections. a pilot. Fam Pract 17 (2000) 386-388
6. Bent B., Saint S., Vittinghoff E., and Grady D. Antibiotics in acute bronchitis. a metaanalysis. Am J Med 107 (1999) 62-67
7. Smucny J., Fahey T., Becker L., Glazier R., and McIsaac W. Antibiotics for acute bronchitis. Cochrane Database Syst Rev (2000) CD000245
8. Knutson D., and Braun C. Diagnosis and management of acute bronchitis. Am Fam Physician 65 (2002) 2039-2044
9. Kayser O., and Kolodziej H. Antibacterial activity of extracts and constituents of Pelargonium sidoides and Pelargonium reniforme. Planta Med 63 (1997) 508-510
10. Kayser O., Kolodziej H., and Kiderlen A.F. Immunomodulatory principles of Pelargonium sidoides. Phytother Res 15 (2001) 122-126
11. Kolodziej H., Kayser O., Radtke O.A., Kiderlen A.F., and Koch E. Pharmacological profile of extracts of Pelargonium sidoides and their constituents. Phytomedicine 10 (2003) 18-24
12. Haidvogl M., Schuster R., and Heger M. Akute Bronchitis im Kindesalter-Multizenter-Studie zur Wirksamkeit und Verträglichkeit des Phytotherapeutikums Umckaloabo. Z Phytotherapie 17 (1996) 300-313
13. Heil C., and Reitermann U. Atemwegs- and HNO-Infektionen. Therapeutische Erfahrungen mit dem Phytotherapeutikum Umckaloabo®. Therapiewoche Pädiatrie 43 (1994) 412-415
14. Blochin B., Haidvogl M., and Heger M. Umckaloabo im Vergleich zu Acetylcystein bei Kindern mit akuter Bronchitis. Der Kassenarzt 49 (1999) 46-50
15. Matthys H., Eisebitt R., Seith B., and Heger M. Efficacy and safety of an extract of Pelargonium sidoides (EPs 7630) in adults with acute bronchitis. A randomised, double-blind, placebo-controlled trial. Phytomedicine 10 suppl IV (2003) 7-17
16. World Medical Association Declaration of Helsinki. Recommendations guiding physicians in biomedical research involving human subjects. JAMA 277 (1997) 925-926
17. European Agency for the Evaluation of Medicinal Products (EMEA). ICH Topic E 6. Guideline for Good Clinical Practice. Note for Guidance on Good Clinical Practice (CPMP/ICH/135/95) (1997)
18. Snow V., Mottur-Pilson C., and Gonzales R. Principles of appropriate antibiotic use for treatment of acute bronchitis in adults. Ann Intern Med 134 (2001) 518-520
19. Lehmacher W., and Wassmer G. Adaptive sample size calculations in group sequential trials. Biometrics 55 (1999) 1286-1290
20. Wassmer G. Statistische Testverfahren für gruppensequentielle und adaptive Pläne in klinischen Studien. Theoretische Konzepte und deren praktische Umsetzung mit SAS (1999), Alexander Mönch, Köln
21. Wassmer G., Eisebitt R., and Coburger S. Flexible interim analyses in clinical trials using multistage adaptive test designs. Drug Inf J 35 (2001) 1131-1146
22. Ware Jr. J.E., Kosinski M., and Keller S.D. A 12-item short-form health survey. Construction of scales and preliminary tests of reliability and validity. Med Care 34 (1996) 220-233
23. Brooks R. EuroQol. the current state of play. Health Policy 37 (1996) 53-72
24. Johnson J.A., and Coons S.J. Comparison of the EQ-5D and SF-12 in an adult US sample. Qual Life Res 7 (1998) 115-120
25. Johnson J.A., Coons S.J., Ergo A., and Szava-Kovats G. Valuation of EuroQOL (EQ-5D) health states in an adult US sample. Pharmacoeconomics 13 (1998) 421-433
26. Kind P., Dolan P., Gudex C., and Williams A. Variations in population health status. results from a United Kingdom national questionnaire survey. BMJ 316 (1998) 736-741
27. Kind P. Measuring quality of life in evaluating clinical interventions. an overview. Ann Med 33 (2001) 323-327
28. European Agency for the Evaluation of Medicinal Products (EMEA). Note for Guidance on Good Clinical Practice. ICH-Guidelines (Human)-Efficacy-Topic E9. Step 4 Note for Guidance on Statistical Principles for Clinical Trials. CPMP/ICH/363/96 (adopted March 1998).
29. Pocock S.J. Group sequential methods in the design and analysis of clinical trials. Biometrika 64 (1977) 191-199
30. Gonzales R., Bartlett J.G., Besser R.E., et al. Principles of appropriate antibiotic use for treatment of uncomplicated acute bronchitis. background. Ann Emerg Med 37 (2001) 720-727
31. Williamson H.A. A randomised, controlled trial of doxycycline in the treatment of acute bronchitis. J Fam Pract 19 (1984) 481-486
32. Léophonte P., Murris-Espin M., Berthier A., and Dayan M. The place of antimicrobial chemotherapy in the treatment of adults with acute bronchitis. a double-blind placebo-controlled trial. Clin Microbiol Infect 4 (1998) 436-441
33. Evans A.T., Husain S., Durairaj L., Sadowski L.S., Charles-Damte M., and Wang Y. Azithromycin for acute bronchitis. a randomised, double-blind, controlled trial. Lancet 359 (2002) 1648-1654
34. Hueston W.J.H., and Mainous III A.G. Acute bronchitis. Am Fam Physician 57 (1998) 1270-1276
35. Kolodziej H., and Schulz V. Umckaloabo-Von der traditionellen Anwendung zum modernen Phytotherapeutikum. Deutsche Apotheker Zeitung 143 (2003) 55-64
36. Fahey T., Stocks N., and Thomas T. Quantitative systematic review of randomised controlled trials comparing antibiotic with placebo for acute cough in adults. BMJ 316 (1998) 906-910
37. Hirschmann J.V. Antibiotics for common respiratory tract infections in adults. Arch Intern Med 162 (2002) 256-264
38. Hall K.K., Philbrick J., and Nadkarni M. Evaluation and treatment of acute bronchitis at an academic teaching clinic. Am J Med Sci 325 (2003) 7-9